Sens. Menendez, Smith Lead Push to Make Sure COVID-19 Vaccine Clinical Trials Continue to Enroll Diverse Participants
December 18, 2020
December 18, 2020
WASHINGTON, Dec. 18 -- Sen. Robert Menendez, D-New Jersey, issued the following news release on Dec. 17:
U.S. Senators Bob Menendez (D-N.J.) and Tina Smith (D-Minn.) today led a group of their Senate colleagues in calling on the U.S. Department of Health and Human Services (HHS), the Food and Drug Administration (FDA) Operation Warp Speed and the U.S. Army Material Command (AMC) to make sure COVID-19 vaccine clinical trials continue to enroll a diverse group of participants.
< . . .
U.S. Senators Bob Menendez (D-N.J.) and Tina Smith (D-Minn.) today led a group of their Senate colleagues in calling on the U.S. Department of Health and Human Services (HHS), the Food and Drug Administration (FDA) Operation Warp Speed and the U.S. Army Material Command (AMC) to make sure COVID-19 vaccine clinical trials continue to enroll a diverse group of participants.
< . . .